Viridian Therapeutics, Inc. (VRDN) earnings
Quarterly results of Viridian Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Viridian Therapeutics, Inc. is expected to report around February 25, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended September 30, 2026) Viridian Therapeutics, Inc. reported revenue of $25.8M (-63.5% on the same quarter a year earlier) and a net loss of $101.2M.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | $25.8M | -63.5% | -$101.2M | - |
| Q2 FY2026 | $284K | +278.7% | -$127.1M | - |
| Q1 FY2026 | $141K | +95.8% | -$104.9M | - |
| Q4 FY2025 | $132K | +83.3% | -$120.4M | - |
| Q3 FY2025 | $70.6M | - | -$34.6M | - |
| Q2 FY2025 | $75K | - | -$100.7M | - |
| Q1 FY2025 | $72K | - | -$86.9M | - |
| Q4 FY2024 | $72K | - | -$79.7M | - |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
When is Viridian Therapeutics, Inc.'s next earnings date?
Viridian Therapeutics, Inc. is expected to report around February 25, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
What were Viridian Therapeutics, Inc.'s latest quarterly results?
For Q3 FY2026, which ended September 30, 2026, Viridian Therapeutics, Inc. reported revenue of $25.8M and a net loss of $101.2M. The figures come from its filing with the SEC.
Is Viridian Therapeutics, Inc.'s revenue growing?
Revenue in Q3 FY2026 was $25.8M, down 63.5% from $70.6M in the same quarter a year earlier.
Get an email when VRDN reports
Follow VRDN and we email you its next results the day they are filed, with the numbers explained.